Literature DB >> 3484792

A novel approach to the generation and identification of experimental hepatic metastases in a murine model.

R Lafreniere, S A Rosenberg.   

Abstract

A reproducible model for the selective generation of liver metastases has been developed. The spleen is exteriorized by means of a small subcostal incision and is directly injected with a 1-ml suspension of tumor cells. Tumor cells flow out of the splenic vein into the portal vein and lodge in the liver. Splenectomy is performed approximately 1 minute after tumor cell injection. The procedure is simple, requires a single operative procedure, and is applicable to a wide variety of tumors. Over a 6-month period, more than 3,000 such procedures with the use of 5 different tumors were performed in C57BL/6 mice, resulting in a 1.9% mortality. For reliable enumeration of the number of hepatic metastatic deposits, a suspension of india ink was injected iv, and the liver was removed and bleached with Fekete's solution. Tumor nodules appeared as discrete white nodules against the black background of normal liver parenchyma. This model provides a useful tool for the study of the experimental therapy of hepatic metastases in mice.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3484792

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  48 in total

1.  Organ distribution of experimental metastases of a human colorectal carcinoma injected in nude mice.

Authors:  J E Price; L M Daniels; D E Campbell; R Giavazzi
Journal:  Clin Exp Metastasis       Date:  1989 Jan-Feb       Impact factor: 5.150

Review 2.  Technical considerations for studying cancer metastasis in vivo.

Authors:  D R Welch
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

3.  Encapsulation of doxorubicin in liver-targeted erythrocytes increases the therapeutic index of the drug in a murine metastatic model.

Authors:  E Zocchi; M Tonetti; C Polvani; L Guida; U Benatti; A De Flora
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

Review 4.  The adoptive immunotherapy of cancer using lymphokine activated killer cells and recombinant interleukin-2.

Authors:  S E Ettinghausen; S A Rosenberg
Journal:  Springer Semin Immunopathol       Date:  1986

5.  Vaccines with enhanced costimulation maintain high avidity memory CTL.

Authors:  Sixun Yang; James W Hodge; Douglas W Grosenbach; Jeffrey Schlom
Journal:  J Immunol       Date:  2005-09-15       Impact factor: 5.422

6.  A novel, clinically relevant animal model of metastatic pancreatic adenocarcinoma biology and therapy.

Authors:  B Wang; Q Shi; J L Abbruzzese; Q Xiong; X Le; K Xie
Journal:  Int J Pancreatol       Date:  2001

Review 7.  Mouse models of metastatic pancreatic adenocarcinoma.

Authors:  K Xie; B Wang; Q Shi; J L Abbruzzese; Q Xiong; X Le
Journal:  Int J Pancreatol       Date:  2001

8.  A murine model for bone marrow metastasis established by an i.v. injection of C-1300 neuroblastoma in A/J mice.

Authors:  M Iwakawa; K Ando; H Ohkawa; S Koike; Y J Chen
Journal:  Clin Exp Metastasis       Date:  1994-05       Impact factor: 5.150

9.  Therapeutic effect of a vaccinia colon oncolysate prepared with interleukin-2-gene encoded vaccinia virus studied in a syngeneic CC-36 murine colon hepatic metastasis model.

Authors:  M Sivanandham; S D Scoggin; N Tanaka; M K Wallack
Journal:  Cancer Immunol Immunother       Date:  1994-04       Impact factor: 6.968

10.  Impact of surgical extent and sex on the hepatic metastasis of colon cancer.

Authors:  Liat Sorski; Ben Levi; Lee Shaashua; Elad Neeman; Marganit Benish; Pini Matzner; Aviad Hoffman; Shamgar Ben-Eliyahu
Journal:  Surg Today       Date:  2013-11-06       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.